Deep brain stimulation in neurological and psychiatric disorders
Peripheral nerve and muscle diseases
After receiving his medical degree then Neurology qualification from the University of Lille 2, Lille, France, Dr Krystkowiak practised for 10 years as a specialist neurologist in Lille University Hospital. Meanwhile, he passed his PhD in Biomechanics and Physiology of Motor Performance in 2003 (University of Paris-Sud, Orsay, France).
He was appointed Professor of Neurology in 2007 and moved to Amiens University Hospital and University of Picardie Jules Verne, Amiens, France, as a consultant neurologist. He also held academic positions such as Vice-President for Healthcare to the Scientific Board of the University of Picardie Jules Verne, and as Vice-Dean of the Faculty of Medicine. He was elected by his peers as Medical Director of Amiens University Hospital, a position he held from 2015 to 2019.
He is presently on leave from the University of Picardie Jules Verne and has joined Mediclinic Airport Road Hospital.
He has over 20 years of experience in the treatment of neurological diseases such as epilepsy, migraine and headache, multiple sclerosis and peripheral nerve and muscle diseases. Furthermore, he has developed expertise in certain areas for which he is considered as a key opinion leader: movement disorders especially Parkinson's disease and related syndromes, Huntington disease, gait disorders and the use of botulinum toxin in neurological disorders. More than 20 years ago, he was one of the pioneers in developing treatment by deep brain stimulation for tremor and Parkinson’s disease, and afterwards, for dystonia and chorea.
As a PhD neuroscientist and an expert in clinical research, he has published over 100 articles in international peer reviewed journals, and as a key opinion leader, he serves as a consultant to a number of pharmaceutical companies (Novartis, Medtronic, Allergan, etc.) and to the French Ministry of Health Service as well.
He is a member of national and international societies such as the French Neurological Society, the Movement Disorders Society and the Huntington Study Group.